C WorldWide Group’s Cardiff Oncology CRDF Stock Holding History

C WorldWide Group’s Portfolio CRDF Stock Details CRDF Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-4,564	Closed	-$1.53M	–	120
2016 Q1	$1.53M	Hold	4,564	–	–	0.03%	85
2015 Q4	$1.77M	Hold	4,564	–	–	0.03%	86
2015 Q3	$1.87M	Buy	4,564 +695	+18%	+$364K	0.03%	86
2015 Q2	$2.83M	Buy	3,869 +555	+17%	+$394K	0.04%	82
2015 Q1	$1.63M	Buy	3,314 +973	+42%	+$415K	0.02%	89
2014 Q4	$725K	Sell	2,341 -1,131	-33%	-$366K	0.01%	90
2014 Q3	$1.13M	Buy	+3,472	New	+$1.04M	0.02%	91

Other funds holding CRDF

Bridger Management New York $150M AUM 17.71% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

MWVC

Morgens Waterfall Vintiadis & Co New York $131M AUM 101.21% 1-Year Est. Return

DADC

D.A. Davidson & Co Great Falls, Montana $18.1B AUM 24.63% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

C WorldWide Group's CRDF Position: Q2 2016 in Review

C WorldWide Group sold out of Cardiff Oncology (CRDF) in Q2 2016, closing a stake of 4,564 shares — an estimated $1.53M sold.

C WorldWide Group first reported a position in CRDF in Q3 2014 and held it in 7 quarters. The position peaked at $2.83M in Q2 2015. 66 funds tracked by Wall St. Rank hold CRDF as of Q2 2016.

C WorldWide Group reported no remaining Cardiff Oncology position as of Q2 2016 after selling out during the quarter.
C WorldWide Group sold 4,564 Cardiff Oncology shares in Q2 2016, an estimated $1.53M.
C WorldWide Group first reported a position in Cardiff Oncology in Q3 2014 and held it in 7 quarters.
C WorldWide Group's Cardiff Oncology position peaked at $2.83M in Q2 2015.
66 funds tracked by Wall St. Rank held Cardiff Oncology as of Q2 2016.

Based on C WorldWide Group's 13F filing for Q2 2016, filed 29 Jul 2016.